Cancer BiologybioRxivPreprint
Organoid-based modeling of platinum resistance identifies KRT17 as both a response mediator and biomarker for targeted therapy in ovarian cancer
Juliane Reichenbach, Juliana Schmid, Sophia Hierlmayer…·Mirjana Kessler
This study identifies KRT17 as a mediator of platinum resistance and a biomarker for targeted therapy in ovarian cancer using organoid models and clinical data.
DOI 10.1101/2025.03.10.642373